Century Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DOL:CN

Go back to Century Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates

Century Therapeutics, Inc. (IPSC) Misses Q2 EPS by 4c

August 11, 2022 7:35 AM EDT

Century Therapeutics, Inc. (NASDAQ: IPSC) reported Q2 EPS of ($0.54), $0.04 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $1.4 million versus the consensus estimate of $1.34 million.

For earnings history and earnings-related data on Century Therapeutics, Inc. (IPSC) click here.

... More